JOURNAL DESCRIPTION

The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.

Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.

Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.

The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.

Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.

The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.

Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.

The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.

Issues journals

Medical Radiology and Radiation Safety. 2025. Vol. 70. № 2

DOI:10.33266/1024-6177-2025-70-2-119-125

V.A. Manukova, I.P. Aslanidis, O.V. Mukhortova,
M.V. Metelkina, I.V. Ekaeva, A.S. Rumyantsev, A.V. Silchenko

11C-Methionine and 18F-Fluorodeoxyglucose PET/CT
in Multiple Myeloma Patients – One-Day Investigation

A.N. Bakulev Scientific Center for Cardiovascular Surgery, Moscow, Russia

Contact person: V.A. Manukova, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

ABSTRACT

Background: To evaluate the impact of PET/СT with 11C-Methionine (MET) and 18F-fluorodeoxyglucose (FDG) on physiological distribution of FDG in patients with multiple myeloma (MM).

Material and methods: 40 patients with a history of MM were included in the analysis, 60 PET/CT exams were conducted: in the 1st group – 20 doubled PET/CT (MET PET/CT followed by FDG PET/CT); in the 2nd group – 20 FDG PET/CT. 

Results: Comparative analysis of the physiological accumulation of FDG in two groups of patients with MM – one group passed one day 11C-MET PET/CT followed by 18F-FDG PET/CT and another group passed standard  18F-FDG PET/CT – revealed no statistically significant difference. SULmax and SULmean was calculated in the right lobe of the liver, in the ascending aorta and in the head of the pancreas. The mean values of liver SULmax were: in the first group – 2.37 ± 0.36, in the second group – 2.46 ± 0.40, p = 0.1. The mean values of aortic SULmax were: in the first group – 1.42 ± 0.25, in the second group – 1.51 ± 0.37, p = 0.11. The mean SULmax values in the pancreatic head were: in the first group – 1.43 ± 0.26, in the second group – 1.59 ± 0.36, p = 0.08.

Conclusion: A one-day MET and FDG PET/CT does not affect the pharmacokinetics of FDG and can be used in MM patients.

Keywords: multiple myeloma, PET/CT, 11C-Methionine, 18F-Fluorodeoxyglucose, one-day investigation

For citation: Manukova VA, Aslanidis IP, Mukhortova OV, Metelkina MV, Ekaeva IV, Rumyantsev AS, Silchenko AV. 11C-Methionine and 18F-Fluorodeoxyglucose PET/CT in Multiple Myeloma Patients – One-Day Investigation. Medical Radiology and Radiation Safety. 2025;70(2):119–125. (In Russian). DOI:10.33266/1024-6177-2025-70-2-119-125

 

References

1. Пурсанова Д.М., Асланиди И.П, Мухортова О.В., Шурупова И.В., Екаева И.В., Трифонова Т.А. ПЭТ/КТ в диагностике инфекционного эндокардита: факторы, влияющие на информативность // Бюллетень НЦССХ им. А.Н.Бакулева РАН. Сердечно-сосудистые заболевания. 2022. Т.23. №S3. С.117 [Pursanova D.M., Aslanidi I.P, Mukhortova O.V., Shurupova I.V., Yekayeva I.V., Trifonova T.A. PET/CT in the Diagnosis of Infective Endocarditis: Factors Affecting the Information Content. Byulleten’ Nauchnogo Tsentra Serdechno-Sosudistoy Khirurgii im. A.N.Bakuleva RAN. Serdechno-Sosudistyye Zabolevaniya = Bulletin of the A.N.Bakulev Scientific Center of Cardiovascular Surgery. Russian Academy of Sciences. Cardiovascular Diseases. 2022;23;S3:117 (In Russ.)].

2. Асланиди И.П., Шурупова И.В., Мухортова О.В., Трифонова Т.А., Пурсанова Д.М., Шавман М.Г. Отдел ядерной диагностики центра им. А.Н.Бакулева: современные достижения и взгляд в будущее // Бюллетень НЦССХ им. А.Н.Бакулева РАН. Сердечно-сосудистые заболевания. 2021. Т.22. №2. С.162-170 [Aslanidi I.P., Shurupova I.V., Mukhortova O.V., Trifonova T.A., Pursanova D.M., Shavman M.G. Department of Nuclear Diagnostics of the A.N. Bakulev Center: Current Achievements and a Look into the Future. Byulleten’ Nauchnogo Tsentra Serdechno-Sosudistoy Khirurgii Im. A.N. Bakuleva RAN. Serdechno-Sosudistyye Zabolevaniya = Bulletin of the A.N.Bakulev Scientific Center of Cardiovascular Surgery. Russian Academy of Sciences. Cardiovascular Diseases. 2021;22;2:162-170 (In Russ.)].

3. Huang J., Chan S.C., Lok V., Zhang L., Lucero-Prisno D.E. 3rd, Xu W., Zheng Z.J., Elcarte E., Withers M., Wong M.C.S. Non-Communicable Disease Global Health Research Group, Association of Pacific Rim Universities. The Epidemiological Landscape of Multiple Myeloma: a Global Cancer Registry Estimate of Disease Burden, Risk Factors, and Temporal Trends. Lancet Haematol. 2022 Sep;9;9:e670-e677. doi: 10.1016/S2352-3026(22)00165-X. Epub 2022 Jul 14. PMID: 35843248.

4. Kwee T.C., Basu S., Saboury B., Ambrosini V., Torigian D.A., Alavi A. A New Dimension of FDG-PET Interpretation: Assessment of Tumor Biology. Eur J Nucl Med Mol Imaging. 2011 Jun;38;6:1158-70. doi: 10.1007/s00259-010-1713-9. Epub 2011 Jan 12. PMID: 21225422. 

5. Rasche L., Angtuaco E., McDonald J.E., Buros A., Stein C., Pawlyn C., Thanendrarajan S., Schinke C., Samant R., Yaccoby S., Walker B.A., Epstein J., Zangari M., van Rhee F., Meissner T., Goldschmidt H., Hemminki K., Houlston R., Barlogie B., Davies F.E., Morgan G.J., Weinhold N. Low Expression of Hexokinase-2 is Associated with False-Negative FDG-Positron Emission Tomography in Multiple Myeloma. Blood. 2017 Jul 6;130;1:30-34. doi: 10.1182/blood-2017-03-774422. Epub 2017 Apr 21. PMID: 28432222. PMCID: PMC5501152. 

6. Lapa C., Knop S., Schreder M., Rudelius M., Knott M., Jörg G., Samnick S., Herrmann K., Buck A.K., Einsele H., Lückerath K. 11C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement. Theranostics. 2016 Jan 1;6;2:254-61. doi: 10.7150/thno.13921. PMID: 26877783. PMCID: PMC4729773.

7. Okasaki M., Kubota K., Minamimoto R., Miyata Y., Morooka M., Ito K., Ishiwata K., Toyohara J., Inoue T., Hirai R., Hagiwara S., Miwa A. Comparison of (11)C-4’-Thiothymidine, (11)C-Methionine, and (18)F-FDG PET/CT for the Detection of Active Lesions of Multiple Myeloma. Ann Nucl Med. 2015 Apr;29;3:224-32. doi: 10.1007/s12149-014-0931-9. Epub 2014 Nov 25. PMID: 25421383; PMCID: PMC4385147.

8. Isoda A., Kaira K., Iwashina M., Oriuchi N., Tominaga H., Nagamori S., Kanai Y., Oyama T., Asao T., Matsumoto M., Sawamura M. Expression of L-Type Amino Acid Transporter 1 (LAT1) as a Prognostic and Therapeutic Indicator in Multiple Myeloma. Cancer Sci. 2014 Nov;105;11:1496-502. doi: 10.1111/cas.12529. Epub 2014 Oct 9. PMID: 25220100. PMCID: PMC4462375. 

9. Filippi L., Frantellizzi V., Bartoletti P., Vincentis G., Schillaci O., Evangelista L. Head-to-Head Comparison between FDG and 11C-Methionine in Multiple Myeloma: A Systematic Review. Diagnostics (Basel). 2023 Jun 9;13;12:2009. doi: 10.3390/diagnostics13122009. PMID: 37370904. PMCID: PMC10296945.

10. Kluge R., Chavdarova L., Hoffmann M., Kobe C., Malkowski B., Montravers F., Kurch L., Georgi T., Dietlein M., Wallace W.H., et al. Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma. PLoSONE. 2016;11:e0149072. doi: 10.1371/journal.pone.0149072. 

11. Siefert J., Kaufmann J., Thiele F., Walter-Rittel T., Rogasch J., Biesen R., Burmester G.R., Amthauer H., Schneider U., Furth C. Performance of Deauville Criteria in [18F]FDG-PET/CT Diagnostics of Giant Cell Arteritis. Diagnostics (Basel). 2023 Jan 3;13;1:157. doi: 10.3390/diagnostics13010157. PMID: 36611449. PMCID: PMC9818714.

12. Lucignani G., Paganelli G., Bombardieri E. The Use of Standardized Uptake Values for Assessing FDG Uptake with PET in Oncology: a Clinical Perspective. Nucl Med Commun. 2004;25:651–656.

13. Sarikaya I., Albatineh A.N., Sarikaya A. Revisiting Weight-Normalized SUV and Lean-Body-Mass-Normalized SUV in PET Studies. J Nucl Med Technol. 2020 Jun;48;2:163-167. doi: 10.2967/jnmt.119.233353. Epub 2019 Oct 11. PMID: 31604893.

14. Riauka T.A., Baracos V.E., Reif R., Juengling F.D., Robinson D.M., Wieler M., McEwan A.J.B. Rapid Standardized CT-Based Method to Determine Lean Body Mass SUV for PET-A Significant Improvement over Prediction Equations. Front Oncol. 2022 Jul 7;12:812777. doi: 10.3389/fonc.2022.812777. PMID: 35875083. PMCID: PMC9302197.

15. Okasaki M., Kubota K., Minamimoto R., Miyata Y., Morooka M., Ito K., Ishiwata K., Toyohara J., Inoue T., Hirai R., Hagiwara S., Miwa A. Comparison of (11)C-4’-Thiothymidine, (11)C-Methionine, and (18)F-FDG PET/CT for the Detection of Active Lesions of Multiple Myeloma. Ann Nucl Med. 2015 Apr;29;3:224-32. doi: 10.1007/s12149-014-0931-9. Epub 2014 Nov 25. PMID: 25421383. PMCID: PMC4385147.

16. Morales-Lozano M.I., Rodriguez-Otero P., Sancho L., Nuñez-Cordoba J.M., Prieto E., Marcos-Jubilar M., Rosales J.J., Alfonso A., Guillen E.F., San-Miguel J., Garcia-Velloso M.J. 11C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET/CT and Prognostic Value. Int J Mol Sci. 2022 Aug 31;23;17:9895. doi: 10.3390/ijms23179895. PMID: 36077292. PMCID: PMC9456410.

17. Bailly C., Leforestier R., Jamet B., Carlier T., Bourgeois M., Guérard F., Touzeau C., Moreau P., Chérel M., Kraeber-Bodéré F., Bodet-Milin C. PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients. Int J Mol Sci. 2017 Feb 18;18;2:445. doi: 10.3390/ijms18020445. PMID: 28218709. PMCID: PMC5343979.

18. Jamet B., Bailly C., Carlier T., Touzeau C., Nanni C., Zamagni E., Barré L., Michaud A.V., Chérel M., Moreau P., Bodet-Milin C., Kraeber-Bodéré F. Interest of Pet Imaging in Multiple Myeloma. Front Med (Lausanne). 2019 Apr 9;6:69. doi: 10.3389/fmed.2019.00069. PMID: 31024917. PMCID: PMC6465522.

19. Nakamoto Y., Kurihara K., Nishizawa M., Yamashita K., Nakatani K., Kondo T., Takaori-Kondo A., Togashi K. Clinical Value of 11C-Methionine PET/CT in Patients with Plasma Cell Malignancy: Comparison with 18F-FDG PET/CT. Eur. J. Nucl. Med. Mol. Imaging. 2013;40:708-715. doi: 10.1007/s00259-012-2333-3. 

20. Callander N.S., Baljevic M., Adekola K., Anderson L.D., Campagnaro E., Castillo J.J., Costello C., Devarakonda S., Elsedawy N., Faiman M., Garfall A., Godby K., Hillengass J., Holmberg L., Htut M., Huff C.A., Hultcrantz M., Kang Y., Larson S., Liedtke M., Martin T., Omel J., Sborov D., Shain K., Stockerl-Goldstein K., Weber D., Berardi R.A., Kumar R., Kumar S.K. NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022. J Natl Compr Canc Netw. 2022 Jan;20;1:8-19. doi: 10.6004/jnccn.2022.0002. PMID: 34991075.

21. Костина И.Э., Гитис М.К., Менделеева Л.П., Баграмян А.Ю., Соловьев М.В., Грибанова Е.О., Савченко В.Г. Рентгеновская компьютерная томография в диагностике и мониторинге поражения костей при множественной миеломе с использованием низкодозового и стандартного протоколов сканирования // Гематология и трансфузиология. 2018. Т.63. №2. С.113-123 [Kostina I.E., Gitis M.K., Mendeleyeva L.P., Bagramyan A.Yu., Solov’yev M.V., Gribanova Ye.O., Savchenko V.G. X-ray Computed Tomography in the Diagnosis and Monitoring of Bone Lesions in Multiple Myeloma Using Low-Dose and Standard Scanning Protocols. Gematologiya i Transfuziologiya = Hematology and Transfusiology. 2018;63;2:113-123 (In Russ.)]. doi: 10.25837/HAT.2018.13.2.002

 

 

 PDF (RUS) Full-text article (in Russian)

 

Conflict of interest. The authors declare no conflict of interest.

Financing. The study had no sponsorship.

Contribution. Development of the research concept and design, research methods, collection and analysis of literary material, statistical data processing, writing and scientific editing of the text – V.A. Manukova, I.P. Aslanidi, O.V. Mukhortova, M.V. Metelkina, I.V. Yekaeva, A.S. Rumyantsev, A.V. Silchenko – in equal parts.

Article received: 20.12.2024. Accepted for publication: 25.01.2025.

 

 

 

Medical Radiology and Radiation Safety. 2025. Vol. 70. № 2

DOI:10.33266/1024-6177-2025-70-2-126-129

Yu.E. Kvacheva 

Memorizing Professor V.V. Shikhodyrov
(to the 100th Anniversary of Birth)

A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia

Contact person: Yu. E. Kvacheva, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

ABSTRACT

This article describes life and professional path of a prominent Russian scientist-radiobiologist, Honored Scientist of the RSFSR, laureate of the Lenin Prize and twice laureate of the USSR State Prize, Doctor of Medical Sciences, Professor V.V. Shikhodyrov and is dedicated to the 100th anniversary of his birth. Biographical and scientific information is supplemented by the author’s personal memories.

Keywords: Shikhodyrov, radiobiology, radiation pathology, prominent scientists-radiobiologists, history of science

For citation: Kvacheva YuE. Memorizing Professor V.V. Shikhodyrov (to the 100th Anniversary of Birth). Medical Radiology and Radiation Safety. 2025;70(2):126–129. (In Russian). DOI:10.33266/1024-6177-2025-70-2-126-129

 

References

1. Shikhodyrov V.V. Izmeneniye Rykhloy Soyedinitel’noy Tkani pri Ostroy Luchevoy Bolezni, Vyzvannoy Vvedeniyem v Organizm Radioaktivnogo Strontsiya (89Sr i 90Sr) i Ittriya (91Y): Vliyaniye Radioaktivnogo Strontsiya na Zhivotnyy Organizm = Changes in Loose Connective Tissue in Acute Radiation Sickness Caused by the Introduction of Radioactive Strontium (89Sr and 90Sr) and Yttrium (91Y) into the Body: Effect of Radioactive Strontium on the Animal Organism. Moscow Publ., 1961. P. 54-60 (In Russ.).

2. Shikhodyrov V.V., Lebedeva G.A., Lebedev B.I. Study of Blastomogenic Effect of Ionizing Radiation on Dogs. Voprosy Onkologii = Questions of Oncology. 1971;5:55-60 (In Russ.).

3. Ivanov A.Ye., Kurshakova N.N., Shikhodyrov V.V. Patologicheskaya Anatomiya Luchevoy Bolezni = Pathological Anatomy of Radiation Sickness. Moscow, Meditsina Publ., 1981. 303 p. (In Russ.).

4. Vidnyye Otechestvennyye Uchenyye v Oblasti Radiobiologii, Radiatsionnoy Meditsiny i Bezopasnosti = Prominent Russian Scientists in the Field of Radiobiology, Radiation Medicine and Safety. Biobibliographic Handbook. Ed. L.A.Il’in, A.S.Samoylov, I.B.Ushakov. Moscow, FMBTS im. A.I. Burnazyana FMBA Rossii Publ., 2021. 616 p. (In Russ.).

5. Fedorenko B.S. Radiobiologicheskiye Effekty Korpuskulyarnykh Izlucheniy: Radiatsionnaya Bezopasnost’ Kosmicheskikh Poletov = Radiobiological Effects of Corpuscular Radiation: Radiation Safety of Space Flights. Ed. V.Shikhodyrov. Moscow, Nauka Publ., 2006. 189 p. (In Russ.).

6. Lebedeva G.A. Moya Zhizn’ v Strane Sovetov = My Life in the Land of Soviets. Moscow, Geoinformservis Publ., 2002. 208 p. (In Russ.).

 

 

 PDF (RUS) Full-text article (in Russian)

 

Conflict of interest. The author declare no conflict of interest.

Financing. The study had no sponsorship.

Contribution. The article was prepared with the sole participation of the author.

Article received: 20.02.2025. Accepted for publication: 25.03.2025.

 

Medical Radiology and Radiation Safety. 2025. Vol. 70. № 1

DOI:10.33266/1024-6177-2025-70-1-5-15

L.A. Romodin1, A.A. Moskovskij1, 4, O.V. Nikitenko1, 2, T.M. Bychkova1, 2,
E.D. Rodionova1, 3, O.M. Tyukalova1

Evaluation of the Protective Effect of the Combined Use of Certain Natural Substances in Acute Exposure to Ionizing Radiation by Mice Physiological Parameters

1 A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia

2 Institute of Biomedical Problems, Moscow, Russia

3 D. I. Mendeleev Russian University of Chemical Technology, Moscow, Russia

4 National Research Nuclear University MEPhI, Moscow, Russia

Contact person: L.A. Romodin, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

ABSTRACT

Relevance: Due to the high chemical toxicity of effective radioprotectors and the low radioprotective effect of low-toxic compounds, the use of several substances as part of a single therapeutic regimen for the treatment of radiation sickness seems promising.

Purpose: Evaluate the radioprotective effect of several therapeutic regimens using different substances on a number of physiological parameters in male ICR (CD-1) mice acutely exposed to X-ray radiation at a dose of 6.5 Gy.

Material and methods: The regimens studied included the use of riboxin (inosine), phenylephrine, glutathione, copper chlorophyllin, two forms of vitamin E (tocopherol, trolox), ascorbic acid and granulocyte stimulating factor (G-CSF) in the form of pegfilgrastim. Efficacy was assessed based on hematological parameters, the content of thiobarbiturate-reactive products in the liver, changes in the weight of the liver, thymus and spleen 4 days or 7 days after irradiation.

Results: Among the parameters assessed, the most striking picture was given by the level of leukocytes in the blood of mice 4 and 7 days after irradiation. None of the schemes used returned this indicator to the vivar control level. The most pronounced increase in the content of leukocytes, compared with the irradiated control group, was observed in mice that were administered phenylephrine before irradiation, 30 minutes after irradiation – glutathione, the next day – tocopherol and G-CSF, followed by daily administrations of G-CSF. At the same time, in the case of joint administration of copper chlorophyllin with G-CSF, the protective effect completely disappeared, and the general condition of the mice became worse than in the irradiated control group. That is, G-CSF is not compatible with copper chlorophyllin. The result also occurred in the group that received tocopherol, glutathione and ascorbic acid on the day of irradiation, a day later – only glutathione, and after 2, 3 and 4 days – copper chlorophyllin. Only in this group was there a correction of thrombocytopenia, which occurred one week after irradiation. The deterioration of the condition of the mice, up to the death of some animals in the group, was caused by intragastric administration of riboxin 1, 2, 3 and 4 days after irradiation.

Сonclusions: The results of the work update research into the possibility of treating radiation sickness using several substances with a mandatory study of the effects of their pharmacological interactions. Growth factors and low molecular weight compounds with sulfhydryl groups seem to us to be the most promising.

Keywords: X-ray radiation, acute exposure, radioprotective substances, combined use, mice 

For citation: Romodin LA, Moskovskij AA, Nikitenko OV, Bychkova TM, Rodionova ED, Tyukalova OM. Evaluation of the Protective Effect of the Combined Use of Certain Natural Substances in Acute Exposure to Ionizing Radiation by Mice Physiological Parameters. Medical Radiology and Radiation Safety. 2025;70(1):5–15. (In Russian). DOI:10.33266/1024-6177-2025-70-1-5-15

 

References

1. Rozhdestvenskiy L.M. Difficulties in Radiation Counter Measure Preparations Development in Russiain Crysis Period: Actual Approaches Searching. Radiatsionnaya Biologiya. Radioekologiya = Radiation Biology. Radioecology. 2020;60;3:279–290 (In Russ.). doi: 10.31857/S086980312003011X.

2. Vernigorova L.A., Zhorova Ye.S., Popov B.A., Parfenova I.M. Combined Prophylactic Administration of Riboxin and Algisorbum at 239Pu Intake into Gastrointestinal Tract of Rats. Radiatsionnaya Biologiya. Radioekologiya = Radiation Biology. Radioecology. 2005;45;2:201–206 (In Russ.).

3. Zhorova Ye.S., Kalistratova V.S., Nisimov P.G., Parfenova I.M., Tishchenko G.S. Complex Application of Indraline and Pherrocine for the Combined Exposure on the Organism of External γ-Irradiation and Incorporation of 137Cs. Radiatsionnaya Biologiya. Radioekologiya = Radiation Biology. Radioecology 2010;50;2:171–179 (In Russ.).

4. Kalistratova V.S., Zhorova Ye.S., Belyayev I.K., Nisimov P.G., Parfenova I.M., Tishchenko G.S. Problems of Acceleration for Radionuclide Decorporation. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost’ = Medical Radiology and Radiation Safety. 2012;57;1: 5–16 (In Russ.).

5. Vasin M.V., Antipov V.V., Komarova S.N., Semonova L.A., Galkin A.A. Radioprotective Properties of Indralin at its Combined Application with Cystamine and Mexamine. Radiatsionnaya Biologiya. Radioekologiya = Radiation Biology. Radioecology. 2011;51;2: 243–246 (In Russ.).

6. Pozdeyev A.V. Experimental study of the content of cortisol in the blood during radiation exposure. Vestnik Kurskoy Gosudarstvennoy Sel’skokhozyaystvennoy Akademii = Bulletin of the Kursk State Agricultural Academy. 2013;7:53–54 (In Russ.).

7. Lysenko N.P., Pak V.V., Rogozhina L.V., Kusurova Z.G. Radiobiologiya = Radiobiology. St. Petersburg, Lan’ Publ., 2023. 572 p. (In Russ.).

8. Vasin M.V. B-190 (Indralin) in the Light of History of Formation of Ideas Of the Mechanism of Action of Radioprotectors. Radiatsionnaya Biologiya. Radioekologiya = Radiation Biology. Radioecology. 2020;60;4:378–395 (In Russ.). doi: 10.31857/S0869803120040128.

9. Geric M., Gajski G., Mihaljevic B., Miljanic S., Domijan A.M., Garaj-Vrhovac V. Radioprotective Properties of Food Colorant Sodium Copper Chlorophyllin on Human Peripheral Blood Cells in Vitro. Mutation Research. Genetic Toxicology and Environmental Mutagenesis. 2019;845:403027. doi: 10.1016/j.mrgentox.2019.02.008.

10. Upadhyaya A., Zhou P., Meng Z., Wang P., Zhang G., Jia Q., Tan J., Li X., Hu T., Liu N., Wang S., Liu X., Wang H., Zhang C., Zhao F., Yan Z., Wang X., Zhang X., Zhang W. Radioprotective Effect of Vitamin E on Salivary Glands After Radioiodine Therapy for Differentiated Thyroid Cancer: a Randomized-Controlled Trial. Nuclear Medicine Communications. 2017;38;11:891–903. doi: 10.1097/MNM.0000000000000727.

11. Torun N., Muratli A., Serim B.D., Ergulen A., Altun G.D. Radioprotective Effects of Amifostine, L-Carnitine and Vitamin E in Preventing Early Salivary Gland Injury due to Radioactive Iodine Treatment. Current Medical Imaging Reviews. 2019;15;4:395–404. doi: 10.2174/1573405614666180314150808.

12. Gonzalez E., Cruces M.P., Pimentel E., Sanchez P. Evidence that the Radioprotector Effect of Ascorbic Acid Depends on the Radiation Dose Rate. Environmental Toxicology and Pharmacology. 2018;62:210–214. doi: 10.1016/j.etap.2018.07.015.

13. Gilevich I.V., Fedorenko T.V., Pashkova I.A., Porkhanov V.A., Chekhonin V.P. Effects of Growth Factors on Mobilization of Mesenchymal Stem Cells. Bulletin of Experimental Biology. 2017;162;5:684–686. doi: 10.1007/s10517-017-3687-0.

14. Averill-Bates D.A. The Antioxidant Glutathione. Vitamins and Hormones. 2023;121:109–141. doi: 10.1016/bs.vh.2022.09.002.

15. Istomina A.A., Chelomin V.P., Dovzhenko N.V., Kurilenko V.V., Fedorets Yu.V., Bel’cheva N.N. Activity of Antioxidant Enzymes and Glutathione Content in the Digestive Organs of Marine Invertebrates from Posyet Bay, Sea of Japan. Biologiya Morya = Biology of the Sea. 2018;44;4:290–296 (In Russ.). doi: 10.1134/S0134347518040101.

16. Hayes J.D., Flanagan J.U., Jowsey I.R. Glutathione Transferases. Annual Review of Pharmacology and Toxicology. 2005;45:51–88. doi: 10.1146/annurev.pharmtox.45.120403.095857.

17. Tang M., Li R., Chen P. Exogenous Glutathione can Alleviate Chromium Toxicity in Kenaf by Activating Antioxidant System and Regulating DNA Methylation. Chemosphere. 2023;337:139305. doi: 10.1016/j.chemosphere.2023.139305.

18. Eroglu A., Dogan Z., Kanak E.G., Atli G., Canli M. Effects of Heavy Metals (Cd, Cu, Cr, Pb, Zn) on Fish Glutathione Metabolism. Environmental Science and Pollution Research International. 2015;22;5:3229–3237. doi: 10.1007/s11356-014-2972-y.

19. Burlakova Ye.B., Alesenko A.V., Molochkina Ye.M., Pal’mina N.P., Khrapova N.G. Bioantioksidanty v Luchevom Porazhenii i Zlokachestvennom Roste = Bioantioxidants in Radiation Injury and Malignant Growth. Moscow, Nauka Publ., 1975. 213 p. (In Russ.).

20. Lin Y., Chen X., Yu C., Xu G., Nie X., Cheng Y., Luan Y., Song Q. Radiotherapy-Mediated Redox Homeostasis-Controllable Nanomedicine for Enhanced Ferroptosis Sensitivity in Tumor Therapy. Acta Biomaterialia. 2023;159:300–311. doi: 10.1016/j.actbio.2023.01.022.

21. Kudryashov Yu.B. Radiatsionnaya Biofizika (Ioniziruyushchiye Izlucheniya). = Radiation Biophysics (Ionizing Radiation). Ed. V.K.Mazurik, M.F.Lomanov. Moscow, Fizmatlit Publ., 2004. 448 p. (In Russ.).

22. Zhuravlyov A.I., Zubkova S.M. Antioksidanty. Svobodnoradikal’naya Patologiya, Starenie = Antioxidants. Free Radical Pathology, Aging. Moscow, Belye al’vy Publ., 2014. 304 p. (In Russ.). 

23. Vasin M.V. Protivoluchevyye Lekarstvennyye Sredstva = Anti-Radiation Drugs. Moscow, Kniga-Memuar Publ., 2020. 239 p. (In Russ.).

24. Jokay I., Kelemenics K., Gyuris A., Minarovits J. S-Methylthio-Cysteine and Cystamine are Potent Stimulators of Thiol Production and Glutathione Synthesis. Life Sciences. 1998;62;2:PL27-33. doi: 10.1016/s0024-3205(97)01066-7.

25. Sharapov M.G., Gudkov S.V., Lankin V.Z., Novoselov V.I. The Role of Glutathione Peroxidases and Peroxiredoxins in Free Radical Pathologies. Biokhimiya = Biochemistry. 2021;86;11:1635–1653 (In Russ.). doi: 10.31857/S0320972521110038.

26. Inal M.E., Akgun A., Kahraman A. Radioprotective Effects of Exogenous Glutathione Against Whole-Body Gamma-Ray Irradiation: Age- and Gender-Related Changes in Malondialdehyde Levels, Superoxide Dismutase and Catalase Activities in Rat Liver. Methods and Findings in Experimental and Clinical Pharmacology. 2002;24;4:209–212. doi: 10.1358/mf.2002.24.4.678452.

27. Foyer C.H., Kunert K. The Ascorbate-Glutathione Cycle Coming of Age. Journal of Experimental Botany. 2024;75;9:2682–2699. doi: 10.1093/jxb/erae023.

28. Yemelyanov V.V., Prikaziuk E.G., Lastochkin V.V., Aresheva O.M., Chirkova T.V. Ascorbate-Glutathione Cycle in Wheat and Rice Seedlings under Anoxia and Subsequent Reaeration. Vavilovskiy Zhurnal Genetiki i Selektsii. 2024;28;1:44–54. doi: 10.18699/vjgb-24-06.

29. Mishra B., Chand S., Singh Sangwan N. ROS Management is Mediated by Ascorbate-Glutathione-Alpha-Tocopherol Triad in Co-ordination with Secondary Metabolic Pathway under Cadmium Stress in Withania Somnifera. Plant Physiology and Biochemistry: PPB. 2019;139:620–629. doi: 10.1016/j.plaphy.2019.03.040.

30. Zerniy Ye.Yu., Golovastova M.O., Baksheyeva V.Ye., Kabanova Ye.I., Ishutina I.Ye., Gancharova O.S., Gusev A.Ye., Savchenko M.S., Loboda A.P., Sotnikova L.F., Zamyatnin A.A., Filippov P.P., Senin I.I Changes in the Biochemical Properties of Lacrimal Fluid During the Development of Chronic Dry Eye Syndrome in the Post-Anesthesia Period. Biokhimiya = Biochemistry. 2017;82;1:137–148. (In Russ.).

31. McClain D.E., Kalinich J.F., Ramakrishnan N. Trolox Inhibits Apoptosis in Irradiated MOLT-4 Lymphocytes. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. 1995;9;13:1345–1354. doi: 10.1096/fasebj.9.13.7557025.

32. Ding S.S., Sun P., Zhang Z., Liu X., Tian H., Huo Y.W., Wang L.R., Han Y., Xing J.P. Moderate Dose of Trolox Preventing the Deleterious Effects of Wi-Fi Radiation on Spermatozoa In vitro through Reduction of Oxidative Stress Damage. Chinese Medical Journal. 2018;131;4:402–412. doi: 10.4103/0366-6999.225045.

33. Kumar S.S., Shankar B., Sainis K.B. Effect of Chlorophyllin against Oxidative Stress in Splenic Lymphocytes In vitro and In vivo. Biochimica et Biophysica Acta. 2004;1672;2:100–111. doi: 10.1016/j.bbagen.2004.03.002.

34. Romodin L.A., Nikitenko O.V., Bychkova T.M., Zrilova YU.A., Rodionova Ye.D., Bocharov D.A. Comparative Evaluation of the Radioprotective Properties of Copper Chlorophyllin, Trolox, and Indralin in an Experiment on Mice. Byulleten’ Eksperimental’noy Biologii i Meditsiny = Bulletin of Experimental Biology and Medicine. 2024;177;3:316–321 (In Russ.). doi: 10.47056/0365-9615-2024-177-3-316-321.

35. Popova N.R., Gudkov S.V., Bruskov V.I.  Natural Purine Compounds as Radioprotective Agents. Radiatsionnaya Biologiya. Radioekologiya = Radiation Biology. Radioecology. 2014;54;1:38–49 (In Russ.). doi: 10.7868/S0869803114010135.

36. Xiang B., Han L., Wang X., Tang L., Li K., Li X., Zhao X., Xia M., Zhou X., Zhang F., Liu K.J. Nicotinamide Phosphoribosyltransferase Upregulation by Phenylephrine Reduces Radiation Injury in Submandibular Gland. International Journal of Radiation Oncology, Biology, Physics. 2016;96;3:538–546. doi: 10.1016/j.ijrobp.2016.06.2442.

37. Eccles R. Substitution of Phenylephrine for Pseudoephedrine as a Nasal Decongeststant. An Illogical Way to Control Methamphetamine Abuse. British Journal of Clinical Pharmacology. 2007;63;1:10–14. doi: 10.1111/j.1365-2125.2006.02833.x.

38. Ilʹin L.A., Rudnyy N.M., Suvorov N.N., Chernov G.A., Antipov V.V., Vasin M.V., Davydov B.I., Mikhaylov P.P. Indralin – Radioprotektor Ekstrennogo Deystviya. Protivoluchevyye Svoystva, Farmakologiya, Mekhanizm Deystvia, Klinika = Indralin – Emergency Radioprotector. Antiradiation Properties, Pharmacology, Mechanism of Action, Clinical Picture. Moscow, Vtoraya Tipografiya Minzdrava RF Publ., 1994. 436 p. (In Russ.).

39. Yamaguchi M., Suzuki M., Funaba M., Chiba A., Kashiwakura I. Mitigative Efficacy of the Clinical Dosage Administration of Granulocyte Colony-Stimulating Factor and Romiplostim in Mice with Severe Acute Radiation Syndrome. Stem Cell Research & Therapy. 2020;11;1:339. doi: 10.1186/s13287-020-01861-x.

40. Mantz J.M. Method for the Quantitative Examination of Bone Marrow of White Rats. Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. 1957;151;11:1957–1960.

41. Gavrilov V.B., Gavrilova A.R., Magul’ L.M. Analysis of Methods for Determining Lipid Peroxidation Products in Blood Serum Using the Thiobarbituric Acid Test. Voprosy Meditsinskoy Khimii = Questions of Medical Chemistry. 1987;33;1:118–122 (In Russ.).

42. Zaitsev S., Mishurov A., Bogolyubova N. Comparative Study of the Antioxidant Protection Level in the Duroc Boar Blood Based on the Measurements of Active Products of the Thiobarbituric Acid. Fundamental and Applied Scientific Research in the Development of Agriculture in the Far East (AFE-2021). 2021;2:500–506. doi: 10.1007/978-3-030-91405-9_55.

43. Abadi S., Shirazi A., Alizadeh A.M., Changizi V., Najafi M., Khalighfard S., Nosrati H. The Effect of Melatonin on Superoxide Dismutase and Glutathione Peroxidase Activity, and Malondialdehyde Levels in the Targeted and the Non-targeted Lung and Heart Tissues after Irradiation in Xenograft Mice Colon Cancer. Current Molecular Pharmacology. 2018;11;4:326–335. doi: 10.2174/1874467211666180830150154.

44. Simonova N.V., Dorovskikh V.A., Kropotov A.V., Kotel’nikova M.A., Shtarberg M.A., Maysak A.G., Chernysheva A.A., Kabar M.A. Comparative Effectiveness of Succinic Acid and Reamberin in the Oxidative Stress in Experiment. Byulleten’ Fiziologii i Patologii Dykhaniya = Bulletin of Physiology and Pathology of Respiration. 2018;70:78–82. doi: 10.12737/article_5c126def73b749.24896834.

45. Pozdeyev A.V., Gugalo V.P. The Effect of Chlorophyll Preparation on the Content of Malonic Dialdehyde in Radiation Pathology. Vestnik Kurskoy Gosudarstvennoy Sel’skokhozyaystvennoy Akademii = Bulletin of the Kursk State Agricultural Academy. 2012;2:107–109 (In Russ.).

46. Gusev Ye.I., Kryzhanovskiy G.N., et al. Dizregulyatsionnaya Patologiya Nervnoy Sistemy = Dysregulatory Pathology of the Nervous System. Moscow, Medical Information Agency Publ., 2009. 455 p. (In Russ.).

47. Ogbuagu N.E., Aluwong T., Ayo J.O., Sumanu V.O. Effect of Fisetin and Probiotic Supplementation on Erythrocyte Osmotic Fragility, Malondialdehyde Concentration and Superoxide Dismutase Activity in Broiler Chickens Exposed to Heat Stress. The Journal of Veterinary Medical Science. 2018;80;12:1895–1900. doi: 10.1292/jvms.18-0477.

48. Cui Y., Liu B., Xie J., Xu P., Habte-Tsion H.M., Zhang Y. Effect of Heat Stress and Recovery on Viability, Oxidative Damage, and Heat Shock Protein Expression in Hepatic Cells of Grass Carp (Ctenopharyngodon Idellus). Fish Physiology and Biochemistry. 2014;40;3:721–729. doi: 10.1007/s10695-013-9879-2.

49. Qari S.A., Alahmadi A.A., Ali S.S., Mohammedsaleh Z.M., Ibrahim R.F.A., El-Shitany N.A. Effect of Prolonged Whole-Body Hyperthermia on Adult Male Rat Testes and the Protective Role of Vitamin C and E: a Histological and Biochemical Stud. Andrologia. 2021;53;7:e14075. doi: 10.1111/and.14075.

50. Panfilov S.V., Kucherenko A.N., Nuzhenko Ye.M., Shestakova V.D., Simonova N.V., Shtarberg M.A. Study of the Possibility of Phytocorrection of Lipid Peroxidation Processes under Hyperthermia Conditions. Kardiovaskulyarnaya Terapiya i Profilaktika = Cardiovascular Therapy and Prevention. 2023;22;S6:92 (In Russ.).

51. Zhou J., Yue S., Xue B., Wang Z., Wang L., Peng Q., Hu R. Effect of Hyperthermia on Cell Viability, Amino Acid Transfer, and Milk Protein Synthesis in Bovine Mammary Epithelial Cells. Journal of Animal Science and Technology. 2022;64;1:110–122. doi: 10.5187/jast.2021.e128.

52. Kabakov A.Ye., Anokhin Yu.N., Lebedeva T.V. Reactions of Normal and Tumor Cells and Tissues to Hyperthermia in Combination with Ionizing Radiation. Review. Radiatsiya i Risk (Byulleten’ Natsional’nogo Radiatsionno-Epidemiologicheskogo Registra) = Radiation and risk (Bulletin of the National Radiation and Epidemiological Registry). 2018;27;4:141–154 (In Russ.). doi: 10.21870/0131-3878-2018-27-4-141-154.

53. Tolkayeva M.S., Filimonova A.N., Vorobey O.A., Yevstratova Ye.S., Petin V.G. Patterns of Manifestation of Synergistic Interaction of Heavy Metals with Hyperthermia or Ionizing Radiation. Radiatsionnaya Biologiya. Radioekologiya = Radiation Biology. Radioecology. 2020;60;5:524–531 (In Russ.). doi: 10.31857/S0869803120050094.

54. Morales-Ramirez P., Garcia-Rodriguez M.C. In vivo Effect of Chlorophyllin on Gamma-Ray-Induced Sister Chromatid Exchange in Murine Bone Marrow Cells. Mutation Research. 1994;320:329–334. doi: 10.1016/0165-1218(94)90085-x.

55. Morales-Ramirez P., Mendiola-Cruz M.T. In vivo Radioprotective Effect of Chlorophyllin on Sister Chromatid Exchange Induction in Murine Spermatogonial Cells. Mutation Research. 1995;344;1-2:73–78. doi: 10.1016/0165-1218(95)90041-1.

56. Romodin L.A., Nikitenko O.V., Bychkova T.M., Zrilova YU.A., Rodionova Ye.D., Bocharov D.A. Comparison of the Radioprotective Properties of Riboxin (Inosine) and Indralin with Prophylactic Administration at Dosages of 100 mg/кg According to the Survival Criterion of Irradiated Mice. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost’ = Medical Radiology and Radiation Safety. 2024;69;2:18–23 (In Russ.). doi: 10.33266/1024-6177-2024-69-2-18-23.

57. Vasin M.V. Classification of Radiation Protection Agents as a Reflection of the Current State and Prospects for the Development of Radiation Pharmacology. Radiatsionnaya Biologiya. Radioekologiya = Radiation Biology. Radioecology. 2013;53;5:459–467 (In Russ.). doi: 10.7868/S0869803113050160.

58. Sychova L.P., Lisina N.I., Shchegoleva R.A., Rozhdestvenskiy L.M. Antimutagenic Effect of Radiation-Protective Drugs in an Experiment on Mice. Radiatsionnaya Biologiya. Radioekologiya = Radiation Biology. Radioecology. 2019;59;4:388–393 (In Russ.). doi: 10.1134/S086980311904012X.

59. Vasin M.V., Ushakov I.B. Potential Ways of Increase in Bogy Resistance to Damaging Action of Ionizing Radiation with the Aids of Radiomitigators. Uspekhi Sovremennoy Biologii = Advances in Modern Biology. 2019;139;3:235–253 (In Russ.). doi: 10.1134/S0042132419030098.

60. Eliseev V.V., Marikhina B.L. Comparative Study of Antihypoxic Properties of Some Nucleosides and Nucleotides. Pharmaceutical Chemistry Journal. 1986;20:160–162. doi: 10.1007/BF00758559.

61. Romodin L.A., Nikitenko O.V., Bychkova T.M., Zrilova Yu.A., Rodionova Ye.D., Bocharov D.A. Evaluation of Acute Toxicity of Chlorophyllin and Trolox for the Possibility of Studying their Radioprotective Properties. Byulleten’ Eksperimental’noy Biologii i Meditsiny = Bulletin of Experimental Biology and Medicine. 2024;177;1:53–56 (In Russ.). doi: 10.47056/0365-9615-2024-177-1-53-56.

62. Sofia R.D., Knobloch L.C. Influence of Acute Pretreatment with Delta 9-Tetrahydrocannabinol on the LD50 of Various Substances that Alter Neurohumoral Transmission. Toxicology and Applied Pharmacology. 1974;28;2:227–234. doi: 10.1016/0041-008x(74)90008-8.

63. Hayes M., Ferruzzi M.G. Update on the Bioavailability and Chemopreventative Mechanisms of Dietary Chlorophyll Derivatives. Nutrition Research. 2020;81:19–37. doi: 10.1016/j.nutres.2020.06.010.

64. Suryavanshi S., Sharma D., Checker R., Thoh M., Gota V., Sandur S.K., Sainis K.B. Amelioration of Radiation-Induced Hematopoietic Syndrome by an Antioxidant Chlorophyllin through Increased Stem Cell Activity and Modulation of Hematopoiesis. Free Radical Biology & Medicine. 2015;85:56–70. doi: 10.1016/j.freeradbiomed.2015.04.007.

 

 

 PDF (RUS) Full-text article (in Russian)

 

Conflict of interest. The authors declare no conflict of interest.

Financing. The research was carried out at the expense of a grant from the Russian Science Foundation No. 23-24-00383, https://rscf.ru/project/23-24-00383 /.

Contribution. Article was prepared with equal participation of the authors.

Article received: 20.10.2024. Accepted for publication: 25.11.2024.

 

 

 

Medical Radiology and Radiation Safety. 2025. Vol. 70. № 2

130 Кошурникова

Nina Aleksandrovna Koshurnikova
24.12.1926‒13.02.2025

 

On February 13, at the age of 98, a famous scientist, doctor of medical sciences, professor, honorary citizen of the city of Ozersk, Nina Aleksandrovna, passed away. She was born in Tomsk. During the difficult war years, she, like all her peers, worked in addition to studying at school (cleared railroad crossings). After graduating from the Novosibirsk Medical Institute in 1949, she worked as an obstetrician-gynecologist, head of the maternity ward at MSO-71 in the city of Chelyabinsk-40 (Chelyabinsk-65, now Ozersk). The workload was heavy, sometimes she had to be on duty in an ambulance for 2 days. From 1953 to 1956, Nina Aleksandrovna studied in clinical residency and graduate school at the Research Institute of Obstetrics and Gynecology of the USSR Ministry of Health. After defending her PhD dissertation in 1958, she was assigned to Branch No. 1 of the Institute of Biophysics of the USSR Ministry of Health (since 2005, the South Ural Institute of Biophysics of the Federal Medical and Biological Agency of Russia), working her way up from junior to chief researcher. She is a highly qualified specialist in the field of occupational pathology and radiation epidemiology, and studied the remote effects of radiation exposure in an experiment, and then in epidemiological studies. She is the author and co-author of more than 230 scientific papers, including 5 monographs. Under her supervision and with her direct participation, topical important scientific and practical issues of occupational pathology were developed and resolved. The results of the research conducted under her supervision were used in the development of radiation safety standards and formed the basis of the federal law "On the social protection of citizens exposed to radiation due to the accident in 1957 at the Mayak production association and the discharge of radioactive waste into the Techa River." On the initiative of N.A. Koshurnikova and with her direct participation, in 1992, a radiation epidemiology laboratory was created at the Branch to study the effects of radiation exposure on the personnel of the Mayak Production Association and the population living in the zone of influence of the nuclear industry enterprise. The laboratory created a medical and dosimetric register of the Mayak Production Association personnel, a children's register for assessing the health status of the descendants of the 1st and 2nd generations of the enterprise personnel and the children's population of the city of Ozersk, located in the zone of influence of the Mayak Production Association, a register of cases of oncological diseases of the residents of the city of Ozersk, a register of liquidators of the 1957 accident. The results of scientific research carried out on these Registers are of exceptionally great scientific significance and were used in the development of radiation safety standards.

Nina Aleksandrovna paid much attention to young specialists; under her supervision, eight PhD theses and one doctoral dissertation were successfully defended. The contribution of Nina Aleksandrovna Koshurnikova in the difficult 90s for the enterprise is invaluable. Thanks to her ability to determine the main thing and not be afraid of difficulties, the Branch of the Institute of Biophysics was preserved. She was one of the first to establish joint scientific contacts with scientists from Japan, the USA, Germany, France and other countries. Nina Aleksandrovna is a recognized and deserved authority in the foreign scientific world. Scientific meetings, conferences, symposia abroad, as well as in Russia, were unthinkable without her active participation. N.A. Koshurnikova successfully combined her extensive scientific and pedagogical work with social activities - for many years she was a member of the City Trade Union Committee, a freelance lecturer at the Public University of the Trade Union Movement. The multifaceted scientific, organizational and social activities of N.A. Koshurnikova has been awarded state awards: the Order of the Red Banner of Labor, the Veteran of Labor medal, the Order of Merit for the Fatherland, IV degree, the Order of Pirogov, departmental badge - "Excellent in Healthcare", "Veteran of Nuclear Power and Industry"; the Academician A.I. Burnazyan badge, the Golden Cross of the Federal Medical and Biological Agency of Russia, honorary certificates of the Governor of the Chelyabinsk Region and the Federal Medical and Biological Agency. Laureate of the Chelyabinsk Region Governor's Prize. An inquisitive mind and inexhaustible vital energy allowed Nina Alexandrovna to pursue science, her favorite occupation throughout her life, until the age of 90.

In her free time, she loved to pick mushrooms, work on her garden plot, ski, and sail a yacht. Not indifferent to other people's problems, she tried to help everyone who turned to her for help. For us, Nina Alexandrovna is a legendary person.

 

 

 PDF (RUS) Full-text article (in Russian)

 

Medical Radiology and Radiation Safety. 2025. Vol. 70. № 1

DOI:10.33266/1024-6177-2025-70-1-16-20

S.S. Sorokina1, V.A. Pikalov2, N.R. Popova1

The Behavioral Effect of Low Dose Carbon Ions Irradiation on Mice in Short-Term Period

1 Institute of Theoretical and Experimental Biophysics, Pushchino, Russia

2 A.A. Logunov Institute of High Energy Physics, Protvino, Russia

Contact person: N.R. Popova, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

ABSTRACT

The active introduction of ion therapy for the treatment of oncological diseases, as well as long-term plans for the exploration of deep space, where crews will be exposed to galactic radiation, the spectrum of which is dominated by protons and high-energy ions - carbon and iron, urgently pose the task of assessing the effect of ions on cognitive functions in order to increase the effectiveness of radiotherapy and ensure the safety of space flights.

Purpose: To study the effect of a therapeutic beam of carbon ions with an energy of 450 MeV/n at the Bragg peak at a dose of 0.7 Gy on the behavior of laboratory mice in the early period after irradiation.

Material and methods: Experiments were carried out on 2-month-old male mice of the SHK (28–32 g.). Before irradiation, the animals were placed on a platform in special containers. Irradiation with a uniform beam of carbon ions with an energy of 450 MeV/n in the Bragg peak at a dose of 0.7 Gy, formed by a “wobbler” magnet, was carried out in the U-70 RBS Collective Use Center (Protvino). Two days after irradiation, the following set of methods was used to assess the general activity, spatial learning, long-term and short-term hippocampus-dependent memory of mice: “open field”, Barnes maze and a novel object recognition test.

Results: It was found that mice whole-body irradiated with a therapeutic beam of carbon ions at a dose of 0.7 Gy do not significantly exhibit an altered model of locomotor and psychoemotional behavior, but they show a deterioration in the memory trace on the 3rd day after training and a violation of episodic memory in the novel object recognition test.

Conclusion: The obtained results complement the accumulating literature data on the effects of low doses of heavy charged particles, and in particular accelerated carbon ions, on the cognitive abilities and behavior of laboratory animals, emphasizing the need to evaluate the observed effects dynamically after exposure.

Keywords: hadron therapy, carbon ions, low doses, behavior, cognitive deficit, radiation safety, mice

For citation: Sorokina SS, Pikalov VA, Popova NR.The Behavioral Effect of Low Dose Carbon Ions Irradiation on Mice in Short-Term Period. Medical Radiology and Radiation Safety. 2025;70(1):16–20. (In Russian). DOI:10.33266/1024-6177-2025-70-1-16-20

 

References

1. Krukowski K., Grue K., Becker M., Elizarraras E., Frias E.S., Halvorsen A., Koenig-Zanoff McK., Frattini V., Nimmagadda H., Feng X., Jones T., Nelson G., Ferguson A.R., Rosi S. The Impact of Deep Space Radiation on Cognitive Performance: From Biological Sex to Biomarkers to Countermeasures. Sci Adv. 2021;7:42:eabg6702. doi: 10.1126/sciadv.abg6702

2. Cucinotta F.A., Cacao E. Predictions of Cognitive Detriments from Galactic Cosmic Ray Exposures to Astronauts on Exploration Missions. Life Sci Space Res (Amst). 2020;25:129-135. doi: 10.1016/j.lssr.2019.10.004

3. Rosi S., Belarbi K., Ferguson R.A., Fishman K., Obenaus A., Raber J., Fike J.R. Trauma-Induced Alterations in Cognition and Arc Expression Are Reduced by Previous Exposure to 56Fe Irradiation. Hippocampus. 2012;22:544-554. doi: 10.1002/hipo.20920

4. Sorokina S.S., Malkov A.E., Shubina L.V., Zaichkina S.I., Pikalov V.A., Low Dose of Carbon Ion Irradiation Induces Early Delayed Cognitive Impairments in Mice. Radiat. Environ. Biophys. 2021;60:61–71. doi: 10.1007/s00411-020-00889-0

5. Sorokina S.S., Zaichkina S.I., Rozanova O.M., Shemyakov A.E., Smirnova E.H., Dyukina A.R., Malkov A.E., Balakin V.E., Pikalov V.A. The Early Delayed Effect of Accelerated Carbon Ions and Protons on the Cognitive Functions of Mice. Biol. Bull. 2020;47: 1651–1658. doi: 10.1134/S1062359020120109

6. Sorokina S.S., Pikalov V.A., Gromova D.S., Popova N.R. Cranial Irradiation of Carbon Ions Effect on the Recognition Memory in Mice. Biol. Bull. 2024;12 (In press).

7. Rola R., Sarkissian V., Obenaus A., Nelson G.A., Otsuka S., Limoli C.L., Fike J.R. High-LET Radiation Induces Inflammation and Persistent Changes in Markers of Hippocampal Neurogenesis. Radiat. Res. 2005;164;4:556–560. doi:10.1667/RR3412.1

8. Liu Y., Yan J., Sun C., Li G., Li S., Zhang L., Di C., Gan L., Wang Y., Zhou R., Si J., Zhang H. Ameliorating Mitochondrial Dysfunction Restores Carbon Ion-Induced Cognitive Deficits via Co-activation of NRF2 and PINK1 Signaling Pathway. Redox Biol. 2018;17:143–157. doi:10.1016/j.redox.2018.04.012

9. Zanni G., Deutsch H., Rivera P., Shih H.-Y., LeBlancJ., Amaral,W., Lucero, M., Redfield R., DeSalle M., Chen B., Whoolery C., Reynolds R., Yun S., Eisch A. Whole-Body 12C Irradiation Transiently Decreases Mouse Hippocampal Dentate Gyrus Proliferation and Immature Neuron Number, but does not Change New Neuron Survival Rate. Int. J. Mol. Sci. 2018;19:3078. doi:10.3390/ijms19103078

10. Serrano C., Dos Santos M., Kereselidze D., Beugnies L., Lestaevel P., Poirier R., Durand C. Targeted Dorsal Dentate Gyrus or Whole Brain Irradiation in Juvenile Mice Differently Affects Spatial Memory and Adult Hippocampal Neurogenesis. Biology. 2021;10;3:192. doi:10.3390/biology10030192

11. Belyaeva A.G., Shtemberg A.S., Nosovsky A.M., Vasil’eva O.N., Gordeev Yu.V., Kudrin V.S., Narkevich V.B., Krasavin E.A., Timoshenko G.N., Lapin B.A., Bazyan A.S. Effect of High-Energy Protons and 12C Carbon Ions on the Cognitive Functions of Monkeys and the Content of Monoamines and their Metabolites in Peripheral Blood. Neurochemistry. 2017;34;1:1–9.

 

 

 PDF (RUS) Full-text article (in Russian)

 

Conflict of interest. The authors declare no conflict of interest.

Financing. The article was prepared as part of the state assignment of the Ministry of Science and Higher Education of the Russian Federation (No. FFRS-2024-0019, ITEB RAS).

Contribution. S.S. Sorokina – development of the research design, conducting the experiment, writing the text of the article; V.A. Pikalov – ensuring the work and conducting an irradiation session at the RBS U-70 Central Research Laboratory (Protvino); N.R. Popova – collection and analysis of literary material, scientific editing of the text, scientific guidance.

Article received: 20.10.2024. Accepted for publication: 25.11.2024.

 

 

Contact Information

 

46, Zhivopisnaya st., 123098, Moscow, Russia Phone: +7 (499) 190-95-51. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Journal location

Attendance

2926520
Today
Yesterday
This week
Last week
This month
Last month
For all time
1537
2221
3758
33458
24816
113593
2926520

Forecast today
2064


Your IP:216.73.216.82